ConductScience.org, home

Paper17657488

Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells.

Karagiannis SN and 12 others. Cancer Immunol Immunother, 2008. Cited by 56 papers, by iCite.

Cite this record

ConductScience Library. Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells. Papers, record 17657488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17657488

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
2008
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
56
iCite
Relative citation ratio, by iCite
1.32
iCite
Revised in PubMed
2025-05-29
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Karagiannis SNSophia N
2Bracher MGMarguerite G
3Beavil RLRebecca L
4Beavil AJAndrew J
5Hunt JJames
6McCloskey NNatalie
7Thompson RGRichard G
8East NNicholas
9Burke FFrances
10Sutton BJBrian J
11Dombrowicz DDavid
12Balkwill FRFrances R
13Gould HJHannah J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibody-Dependent Cell CytotoxicityMajor topic
ImmunotherapyMajor topic
MonocytesMajor topic
Ovarian NeoplasmsMajor topic
PhagocytosisMajor topic
Receptors, IgEMajor topic
Animals
Cell Line, Tumor
Female
Flow Cytometry
Fluorescent Antibody Technique
Humans
Mice
Mice, Nude

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
G0200486Medical Research CouncilUnited KingdomPubMed
G0501974Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12972386Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression.Cell1988https://conductscience.org/library/papers/2972386PubMed
21717147Folate-binding protein is a marker for ovarian cancer.Cancer Res1991https://conductscience.org/library/papers/1717147PubMed
38634249Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domains.Biochemistry1996https://conductscience.org/library/papers/8634249PubMed
410960668Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcvarepsilonR1 signaling pathway.Immunopharmacology2000https://conductscience.org/library/papers/10960668PubMed
51717839Characterization of new rat anti-mouse IgE monoclonals and their use along with chimeric IgE to further define the site that interacts with Fc epsilon RII and Fc epsilon RI.Mol Immunol1991https://conductscience.org/library/papers/1717839PubMed
68428622Isolation and biochemical characterization of the soluble and membrane forms of folate binding protein expressed in the ovarian carcinoma cell line IGROV1.FEBS Lett1993https://conductscience.org/library/papers/8428622PubMed
79799353Dosimetric analysis of chimeric monoclonal antibody cMOv18 IgG in ovarian carcinoma patients after intraperitoneal and intravenous administration.Eur J Nucl Med1998https://conductscience.org/library/papers/9799353PubMed
82713487Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype.Blood1989https://conductscience.org/library/papers/2713487PubMed
91531998Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes.J Immunol1992https://conductscience.org/library/papers/1531998PubMed
1010556807Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma.Eur J Immunol1999https://conductscience.org/library/papers/10556807PubMed
117947461Involvement of Fc epsilon RII/CD23 and L-arginine-dependent pathway in IgE-mediated stimulation of human monocyte functions.Int Immunol1994https://conductscience.org/library/papers/7947461PubMed
121401914Regulation of low affinity IgE receptor (CD23) expression on mononuclear phagocytes in normal and asthmatic subjects.J Immunol1992https://conductscience.org/library/papers/1401914PubMed
1317531261Three-colour flow cytometric method to measure antibody-dependent tumour cell killing by cytotoxicity and phagocytosis.J Immunol Methods2007https://conductscience.org/library/papers/17531261PubMed
1416617160Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response.J Leukoc Biol2006https://conductscience.org/library/papers/16617160PubMed
1516622479Potent antibody therapeutics by design.Nat Rev Immunol2006https://conductscience.org/library/papers/16622479PubMed
1610742152Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets.Nat Med2000https://conductscience.org/library/papers/10742152PubMed
178674126The Fc(epsilon)RIbeta subunit functions as an amplifier of Fc(epsilon)RIgamma-mediated cell activation signals.Cell1996https://conductscience.org/library/papers/8674126PubMed
1812818520Renaissance of cancer therapeutic antibodies.Drug Discov Today2003https://conductscience.org/library/papers/12818520PubMed
192425938Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons.Cancer Res1986https://conductscience.org/library/papers/2425938PubMed
209933083Cellular requirements for the monoclonal antibody-mediated eradication of an established solid tumor.Eur J Immunol1999https://conductscience.org/library/papers/9933083PubMed

See all 51 referencesDownload CSV of references

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMIDTitleJournalYearIn PapersSource
42694955Targeting Folate Receptors for the Detection and Selective Treatment of Cancer: Advanced Precision Oncology in Practice.Int J Biol Sci2026https://conductscience.org/library/papers/42694955PubMed
41672926AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes.Clin Exp Allergy2026https://conductscience.org/library/papers/41672926PubMed
41567205The role of immunoglobulin E in non-atopic disorders.Front Immunol2025https://conductscience.org/library/papers/41567205PubMed
40045156Folate receptor alpha for cancer therapy: an antibody and antibody-drug conjugate target coming of age.MAbs2025https://conductscience.org/library/papers/40045156PubMed
39833133Physiochemical and functional evaluation of the first-in-class anti-cancer IgE antibody drug, MOv18, through process development and good manufacturing practice production.MAbs2025https://conductscience.org/library/papers/39833133PubMed
39273499
Peripheral Inflammation Featuring Eosinophilia or Neutrophilia Is Associated with the Survival and Infiltration of Eosinophils within the Tumor among Various Histological Subgroups of Patients with NSCLC.
Int J Mol Sci2024https://conductscience.org/library/papers/39273499PubMed
37491373Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial.Nat Commun2023https://conductscience.org/library/papers/37491373PubMed
37370828Allergic Diseases and Risk of Malignancy of Gastrointestinal Cancers.Cancers (Basel)2023https://conductscience.org/library/papers/37370828PubMed
37239049The Very Low IgE Producer: Allergology, Genetics, Immunodeficiencies, and Oncology.Biomedicines2023https://conductscience.org/library/papers/37239049PubMed
36197112B cells defined by immunoglobulin isotypes.Clin Exp Immunol2022https://conductscience.org/library/papers/36197112PubMed
34513315In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpart.Oncoimmunology2021https://conductscience.org/library/papers/34513315PubMed
34503270Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments.Cancers (Basel)2021https://conductscience.org/library/papers/34503270PubMed
33081206IgE Antibodies against Cancer: Efficacy and Safety.Antibodies (Basel)2020https://conductscience.org/library/papers/33081206PubMed
31544825IgE Antibodies: From Structure to Function and Clinical Translation.Antibodies (Basel)2019https://conductscience.org/library/papers/31544825PubMed
31388397AllergoOncology: High innate IgE levels are decisive for the survival of cancer-bearing mice.World Allergy Organ J2019https://conductscience.org/library/papers/31388397PubMed
31167464Mast Cells and Natural Killer Cells-A Potentially Critical Interaction.Viruses2019https://conductscience.org/library/papers/31167464PubMed
30956175IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states.EBioMedicine2019https://conductscience.org/library/papers/30956175PubMed
29686678Immunoglobulin E-Mediated Autoimmunity.Front Immunol2018https://conductscience.org/library/papers/29686678PubMed
29654623An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE.Allergy2018https://conductscience.org/library/papers/29654623PubMed
29593727Effect of VH-VL Families in Pertuzumab and Trastuzumab Recombinant Production, Her2 and FcγIIA Binding.Front Immunol2018https://conductscience.org/library/papers/29593727PubMed

See all 40 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FCER1A2205PubTator's text mininghttps://conductscience.org/library/genes/2205NCBI Gene
FCER22208PubTator's text mininghttps://conductscience.org/library/genes/2208NCBI Gene
FOLR12348PubTator's text mininghttps://conductscience.org/library/genes/2348NCBI Gene
IGHE3497PubTator's text mininghttps://conductscience.org/library/genes/3497NCBI Gene
IL43565PubTator's text mininghttps://conductscience.org/library/genes/3565NCBI Gene
LGALS33958PubTator's text mininghttps://conductscience.org/library/genes/3958NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17657488

GET https://conductscience.org/api/papers/v1/17657488/references?page=2